Topical pyridostigmine for ocular myasthenia gravis: a translational hypothesis. [PDF]
Ing EB +6 more
europepmc +1 more source
Delayed diagnosis of ocular myasthenia gravis in a patient with aponeurotic ptosis: A case report. [PDF]
Xie J, Zhang H, Ye J.
europepmc +1 more source
Miastenia grave y miastenia grave ocular
La miastenia grave es una enfermedad caracterizada por debilidad y fatiga de los músculos voluntarios debido a una trasmisión anómala a nivel de la unión neuromuscular. La prevalencia es aproximadamente de 5 casos/100 000 personas.
Rosa María Naranjo Fernández +4 more
doaj
Untargeted serum metabolomic profiling in patients with generalized and ocular myasthenia gravis. [PDF]
Wei B, Yuan H, He J, Hu Y, Li J, Wu X.
europepmc +1 more source
Identification of Ocular and Systemic Predictors and Development of a Prediction Model in Ocular Myasthenia Gravis. [PDF]
Cai Y +5 more
europepmc +1 more source
Ocular myasthenia gravis and thymoma
Victor Alegre-Ituarte +2 more
doaj +1 more source
Early Relapse Frequency as a Potential Predictor of Generalization in Ocular Myasthenia Gravis: A Case Report. [PDF]
Terai J +3 more
europepmc +1 more source
Validation and clinical utility of OMGRate and MG-QOL15 in evaluating symptoms and quality of life in Chinese patients with ocular myasthenia gravis. [PDF]
Tang T +6 more
europepmc +1 more source
Clinical Features and Outcomes of Ocular Myasthenia Gravis in a Tertiary Philippine Hospital. [PDF]
Labiano AT, Cruz FMO, Mesina BVQ.
europepmc +1 more source
Risk factors for generalization of ocular myasthenia gravis. [PDF]
Djordjevic IS +7 more
europepmc +1 more source

